Eli Lilly and (LLY)
NYSE: LLY
· Real-Time Price · USD
763.75
-21.28 (-2.71%)
At close: Jun 20, 2025, 3:59 PM
766.00
0.29%
Pre-market: Jun 23, 2025, 09:20 AM EDT
Eli Lilly and Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 |
|---|---|---|---|---|---|---|
| Collaboration and Other Revenue Revenue | 4.29B | 5.31B | 3.08B | 2.36B | 1.84B | 1.94B |
| Collaboration and Other Revenue Revenue Growth | -19.12% | +72.49% | +30.42% | +27.94% | -5.00% | n/a |
| Product Revenue | 40.75B | 28.81B | 25.46B | 25.96B | 22.69B | 20.38B |
| Product Revenue Growth | +41.42% | +13.16% | -1.91% | +14.38% | +11.37% | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| China Revenue | 1.66B | 1.54B | 1.45B | 1.66B | 1.12B | 3.77B | 4.23B | 3.39B | 3.77B | 3.94B | 4.51B | 4.34B | 4.26B |
| China Revenue Growth | +7.84% | +5.98% | -12.56% | +48.75% | -70.33% | -11.02% | n/a | n/a | -4.45% | -12.49% | +3.88% | +1.85% | n/a |
| Europe Revenue | 6.92B | 6.17B | 4.3B | 4.78B | 4.19B | 2.55B | 14.64B | 2.34B | 2.33B | 2.03B | 2.03B | 2.06B | 2.25B |
| Europe Revenue Growth | +12.08% | +43.62% | -10.00% | +14.07% | +64.38% | -82.59% | n/a | n/a | +14.65% | +0.30% | -1.78% | -8.12% | n/a |
| Japan Revenue | 1.81B | 1.67B | 1.75B | 2.37B | 2.58B | 12.72B | 2.49B | 11.41B | 11.51B | 10.1B | 9.13B | 3.82B | 3.78B |
| Japan Revenue Growth | +8.51% | -4.28% | -26.18% | -8.37% | -79.70% | +410.19% | n/a | n/a | +13.95% | +10.55% | +139.04% | +0.97% | n/a |
| Non-Us Revenue | 4.27B | 2.95B | 2.85B | 2.7B | 14.23B | n/a | n/a | n/a | n/a | n/a | n/a | 12.89B | 12.31B |
| Non-Us Revenue Growth | +44.98% | +3.30% | +5.54% | -81.01% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | +4.68% | n/a |
| United States Revenue | 30.38B | 21.79B | 18.19B | 16.81B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| United States Revenue Growth | +39.39% | +19.80% | +8.20% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 2.36B | 2.42B | 2.1B | 2B | 1.84B | 1.92B | 1.8B | 1.93B | 1.75B | 1.55B | 1.61B | 1.63B | 1.56B | 1.52B | 1.58B | 1.69B | 1.58B | 1.55B | 1.57B | 1.45B | 1.55B | 1.7B | 1.41B | 1.59B | 1.52B | 1.79B | 1.62B | 1.65B | 1.5B | 2.29B | 1.56B | 1.71B | 1.54B | 1.79B | 1.57B | 1.62B | 1.47B | 1.8B | 1.58B | 1.64B | 1.52B |
| Selling, General, and Administrative Revenue Growth | -2.57% | +15.46% | +4.84% | +9.08% | -4.60% | +6.69% | -6.31% | +10.07% | +12.83% | -3.96% | -0.67% | +4.31% | +2.53% | -3.71% | -6.39% | +6.96% | +1.42% | -0.97% | +8.32% | -6.52% | -8.75% | +20.24% | -10.97% | +4.56% | -15.42% | +10.95% | -2.24% | +10.25% | -34.62% | +47.49% | -8.90% | +10.53% | -13.71% | +14.35% | -3.53% | +10.09% | -18.04% | +14.13% | -3.65% | +7.34% | n/a |
| Research and Development Revenue | 2.73B | 3.02B | 2.73B | 2.71B | 2.52B | 2.56B | 2.41B | 2.36B | 1.99B | 2B | 1.8B | 1.78B | 1.61B | 1.96B | 1.71B | 1.67B | 1.68B | 1.84B | 1.47B | 1.39B | 1.39B | 1.58B | 1.38B | 1.4B | 1.23B | 1.45B | 1.34B | 1.33B | 1.18B | 1.47B | 1.32B | 1.25B | 1.24B | 1.45B | 1.24B | 1.34B | 1.22B | 1.44B | 1.14B | 1.17B | 1.04B |
| Research and Development Revenue Growth | -9.56% | +10.55% | +0.84% | +7.47% | -1.56% | +6.38% | +2.23% | +18.71% | -0.54% | +10.70% | +1.18% | +10.67% | -17.83% | +14.66% | +2.16% | -0.71% | -8.34% | +25.43% | +5.41% | -0.14% | -11.97% | +14.52% | -1.52% | +13.95% | -15.36% | +8.23% | +0.77% | +13.27% | -20.11% | +11.66% | +5.48% | +1.02% | -14.64% | +17.32% | -7.45% | +9.41% | -15.45% | +26.31% | -2.23% | +12.53% | n/a |